SCHEMBL20235166

SCHEMBL20235166

COC(=O)C(C)C1CCc2cc(O)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.51
ESR2 Q92731 7/20 0.51
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ACHE P22303 1/20 0.41
GHSR Q92847 1/20 0.41
CYP19A1 P11511 2/20 0.40
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP12 P39900 1/20 0.39
MMP14 P50281 1/20 0.39
MMP15 P51511 1/20 0.39
MMP16 P51512 1/20 0.39
MMP26 Q9NRE1 1/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 2/20 0.39
MEN1 O00255 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL820655 1.00 ESR1 (0.51) ESR1ESR2CA1CA2ACHE
SCHEMBL27661436 1.00 ESR1 (0.51) ESR1ESR2CA1CA2ACHE
SCHEMBL820930 1.00 ESR1 (0.51) ESR1ESR2CA1CA2ACHE
SCHEMBL28750802 1.00 ESR1 (0.51) ESR1ESR2CA1CA2ACHE
SCHEMBL13048137 0.89 MTNR1A (0.44) ESR1ESR2CA1CA2ACHE
SCHEMBL3410085 0.89 MTNR1A (0.44) ESR1ESR2CA1CA2ACHE
SCHEMBL13048165 0.89 MTNR1A (0.44) ESR1ESR2CA1CA2ACHE
SCHEMBL3410091 0.89 MTNR1A (0.44) ESR1ESR2CA1CA2ACHE
SCHEMBL3412451 0.89 MTNR1A (0.44) ESR1ESR2CA1CA2ACHE
SCHEMBL3412455 0.89 MTNR1A (0.44) ESR1ESR2CA1CA2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018102399-A1 METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES T3D THERAPEUTICS, INC. (US) 2018-06-07 WO disclosed